Table 2.

Epilepsy syndromes and some conditions in which the KD therapies has been reported possible benefit (one case report or series)^∗.

Adenylosuccinate lyase deficiency

CDKL5 encephalopathy

Childhood absence epilepsy

Cortical malformations

Epilepsy of infancy with migrating focal seizures

Epileptic encephalopathy with continuous spike-and-wave during sleep

Glycogenosis type V65 Juvenile myoclonic epilepsy

Lafora body disease

Landau-Kleffner syndrome

Lennox-Gastaut syndrome

Phosphofructokinase deficiency

Rett syndrome

Subacute sclerosing panencephalitis (SSPE)

^∗Adapted from Kossoff et al. (2018). Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group (Kossoff et al., 2018).